Oxygen toxicity in premature infants

Toxicology and Applied Pharmacology

Volumn 181, Issue 1, 2002, Pages 60-67

  Weinberger, Barry ^a   Laskin, Debra L ^b   Heck, Diane E ^b   Laskin, Jeffrey D ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Antioxidant; Oxygen; Premature; Toxicity

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; GROWTH FACTOR; OXYGEN; PROTEINASE; REACTIVE OXYGEN METABOLITE;

AERATION; AMBIENT AIR; CHRONIC LUNG DISEASE; HUMAN; INFANT; LIGHT EXPOSURE; LUNG DYSPLASIA; OXYGEN TOXICITY; PREMATURITY; RESPIRATORY FAILURE; RESUSCITATION; RETINA NEOVASCULARIZATION; RETROLENTAL FIBROPLASIA; REVIEW; VASOCONSTRICTION;

EID: 0037095036     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2002.9387     Document Type: Review

References (92)

1. Vascular endothelial growth factor and the eye: Past, present, and future
2. Selenium in premature infants
3. Changes in the pathogenesis and prevention of chronic lung disease of prematurity
4. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants
5. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury
6. Significant reduction of the panretinal oxygenation response after 28% supplemental oxygen recovery in experimental ROP
7. The influence of indomethacin on retinopathy of prematurity
8. Survival, morbidity, and resource use of infants of 25 weeks' gestational age or less
9. Antioxidant-dependent amelioration of brain injury: Role of Cu-Zn-superoxide dismutase
10. Protective effects of liposome-entrapped superoxide dismutase on post-traumatic brain edema
11. The apparent role of blood transfusions in the development of retinopathy of prematurity
12. Taurine deficiency in the severe hepatic dysfunction complicating total parenteral nutrition
13. 2 modulation of intraretinal oxygen levels in an avascular retina
14. A novel model of retinopathy of prematurity simulating preterm oxygen variability in the rat
15. Differential effects of oxygen and barotrauma on lung injury in the neonatal piglet
16. Oxygen toxicity in the premature baboon with hyaline membrane disease
17. Free radicals as mediators of tissue injury
18. Possible implication of photooxidation reactions in retinal photodamage
19. Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal vascularization in the rat
20. Steroids, chronic lung disease, and retinopathy of prematurity
21. Arterial partial pressure of oxygen required to achieve 90% saturation of hemoglobin in very low birth weight newborns
22. Effect of intramuscular vitamin E on frequency and severity of retrolental fibroplasia. A controlled trial
23. Antioxidants, nutrition and bronchopulmonary dysplasia
24. Development of lung antioxidant enzyme system in late gestation: Possible implications for the prematurely-born infant
25. Prenatal development of lung antioxidant enzymes in four species
26. Failure of premature rabbits to increase antioxidant enzymes during hyperoxic exposure: Increased susceptibility to pulmonary oxygen toxicity compared with term rabbits
27. Liposome-mediated augmentation of superoxide dismutase in endothelial cells prevents oxygen injury
28. Supplemental oxygen may decrease progression of prethreshold disease to threshold retinopathy of prematurity
29. Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study
30. Liver membrane composition after short-term parenteral nutrition with and without taurine in guinea pigs
31. Changes in structure, mechanics, and insulin-like growth factor-related gene expression in the lungs of newborn rats exposed to air or 60% oxygen
32. Oxygen therapy, oxygen toxicity, and the STOP-ROP trial
33. Blood transfusion: Iron load and retinopathy of prematurity
34. Suppression of severe retinopathy of prematurity with vitamin E supplementation: Ultrastructural mechanism of clinical efficacy
35. Selenium supplementation in low birth weight premature infants: Relationship to trace metals and antioxidant enzymes
36. Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats
37. High iron status in very low birthweight infants is associated with an increased risk of retinopathy of prematurity
38. Oxygen toxicity in the rhesus monkey: Effects on regulatory peptides in lung and blood
39. Oxygen toxicity
40. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation
41. Time course of vitamin E repletion in the premature infant
42. The total free radical trapping ability of cord blood plasma in preterm and term babies
43. Selenium deficiency in low birthweight infants: An unrecognized problem
44. Oxygen-derived free radicals in postischemic tissue injury
45. Idiopathic pulmonary fibrosis: A paradigm for lung injury and repair
46. Catalase, superoxide dismutase and glutathione peroxidase activities of lung and liver during human development
47. Endocytosis-independent uptake of liposome-encapsulated superoxide dismutase prevents the killing of cultured hepatocytes by tert-butyl hydroperoxide
48. Indomethacin improves oxygen-induced retinopathy in the mouse
49. Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity
50. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance
51. Glutathione status in retinopathy of prematurity
52. 2 variation determines the severity of oxygen-induced retinopathy in newborn rats
53. Oxygen-induced retinopathy in the rat: Vitamins C and E as potential therapies
54. Effect of a water-soluble vitamin E analog, Trolox C, on retinal vascular development in an animal model of retinopathy of prematurity
55. Oxygen-induced retinopathy in the rat: Relationship of retinal nonperfusion to subsequent neovascularization
56. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity
57. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia
58. Hypoxanthine, xanthine, and uric acid in newborn pigs during hypoxemia followed by resuscitation with room air or 100% oxygen
59. Use of indomethacin and its relationship to retinopathy of prematurity in very low birth weight infants
60. Severe retinopathy of prematurity in extremely low birthweight infants after short-term dexamethasone therapy
61. Resuscitation of asphyxic newborn infants with room air or 100% oxygen
62. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants
63. Lack of efficacy of light reduction in preventing retinopathy of prematurity: Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group
64. Modification of oxygen toxicity after lung injury by bleomycin in hamsters
65. Hypoxemia and reoxygenation with 21% or 100% oxygen in newborn pigs: Changes in blood pressure, base deficit, and hypoxanthine and brain morphology
66. Dexamethasone reduces oxygen induced retinopathy in a mouse model
67. Effect of intravitreal administration of indomethacin on experimental subretinal neovascularization in the subhuman primate
68. Plasma hypoxanthine concentrations in pigs: A prognostic aid in hypoxia
69. Resuscitation of asphyxiated infants with room air or oxygen: An international controlled trial: The Resair 2 study
70. Oxygen therapy in acute retinopathy of prematurity stage 3
71. Chronic vascular pulmonary dysplasia associated with neonatal hyperoxia exposure in the rat
72. Vitamin E status of the newborn in relation to gestational age, birth, weight and maternal vitamin E status
73. Hyperoxia-induced airway remodeling and pulmonary neuroendocrine cell hyperplasia in the weanling rat
74. Prolonged dexamethasone therapy reduces the incidence of cryotherapy for retinopathy of prematurity in infants less than 1 kilogram birthweight with bronchopulmonary dysplasia
75. Liposome-entrapped superoxide dismutase reduces ischemia/reperfusion oxidative stress in gerbil brain
76. Effect of light and hyperoxia on ocular blood flow in the newborn piglet
77. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I. Primary outcomes
78. Serum antioxidant activity in neonates
79. Physiologic development of the cardiovascular system in the fetus
80. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation
81. Glutathione peroxidase and selenium levels in the preterm infant
82. Postnatal changes in plasma chain-breaking antioxidants in healthy preterm infants fed formula and/or human milk
83. Functional and pathological effects of prolonged hyperoxia in neonatal mice
84. Intercellular adhesion molecule-1 contributes to pulmonary oxygen toxicity in mice: Role of leukocytes revised
85. Oxygen toxicity to the developing lung of the mouse: Role of reactive oxygen species
86. Immediate decline in DNA synthesis in neonatal rat lung caused by exposure to 100% oxygen
87. Lack of association of glucocorticoid therapy and retinopathy of prematurity
88. Retinopathy of prematurity (ROP) and indomethacin therapy in premature infants with patent ductus arteriosus (PDA)
89. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: A double-blind, controlled study